|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Is there a role for treatment-oriented surgery in liver metastases from gastric cancer?显示文摘BACKGROUND Distant metastases are found in approximately 35%of patients with gastric cancer at their first clinical observation,and of these,4%-14%involves the liver.Unfortunately,only 0.4%-2.3%of patients with metastatic gastric cancer are eligible for radical surgery.Although surgical resection for gastric cancer metastases is still debated,there have been changes in recent years,although several clinical issues remain to be defined and that must be taken into account before surgery is proposed.AIM To analyze the clinicopathological factors related to primary gastric tumor and metastases that impact the survival of patients with liver metastatic gastric cancer.METHODS We performed a systematic review of the literature from 2000 to 2018 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.The study protocol was based on identifying studies with clearly defined purpose,eligibility criteria,methodological analysis,and patient outcome.RESULTS We selected 47 studies pertaining to the purpose of the review,which involved a total of 2304 patients.Median survival was 7-52.3 mo,median disease-free survival was 4.7-18 mo.The 1-,2-,3-,and 5-year overall survival(OS)was 33%-90.1%,10%-60%,6%-70.4%,and 0%-40.1%,respectively.Only five papers reported the 10-year OS,which was 5.5%–31.5%.The general recurrence rate was between 55.5%and 96%,and that for hepatic recurrence was between 15%and 94%.CONCLUSION Serous infiltration and lymph node involvement of the primary cancer indicate an unfavorable prognosis,while the presence of single metastasis or≤3 metastases associated with a size of<5 cm may be considered data that do not contraindicate liver resection. | Fabio Uggeri Lorenzo Ripamonti Enrico Pinotti Mauro Alessandro Scotti Simone Famularo Mattia Garancini Luca Gianotti Marco Braga Fabrizio Romano | 2020 | World Journal of Clinical Oncology2020,11,7: | 3 |
| 2 | High-performance liquid chromatographic assay of ampicillin and its prodrug lenampicillin显示文摘 | Marzo A Mont N Ripamonti M | 1990 | JChromatogr1990,16,: | 2 |
| 3 | Role of Octreotide, Scopolamine Butylbromide, and Hydration in Symptom Control of Patients with Inoperable Bowel Obstruction and Nasogastric Tubes显示文摘 | Carla Ripamonti Sebastiano Mercadante Liliana Groff Ernesto Zecca Franco De Conno Alessandra Casuccio | 2000 | Journal of Pain and Symptom Management2000,,1: | 2 |
| 4 | Comparison between numerical rat- ing scale and six-level verbal rating scale in cancer patients with pain : a preliminary report显示文摘 | Ripamonti CI Brunelli C | 2009 | Support Care Cancer2009,17,11: | 1 |
| 5 | Creep behavior of INCOLOY alloy 617显示文摘 | Marcello Cabibbo Elisabetta Gariboldi Stefano Spigarelli Dario Ripamonti | 2008 | Journal of Materials Science2008,,8: | 1 |
| 6 | A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazoeine in cancer pain显示文摘 | DECONNO F RIPAMONTI C SBANOTTO A | 1991 | J Pain Symptom Manage1991,6,7: | 1 |
| 7 | Role of octreotide,scopolamine butylbromide,and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes:a prospective randomized trial显示文摘 | Ripamonti C Mercadante S Groff L | | 0,,01: | 1 |
| 8 | Independent modal control for nonlinear flexible structures : an experimental test rig 显示文摘 | Resta F Ripamonti F Cazzulani G | 2010 | Journal of Sound and Vibration2010,329,8: | 1 |
| 9 | The role of somatostatin and octreotide in bowel obstruction :Preclinical results显示文摘 | Ripamonti C Panzefi C Groff L | 2001 | Tumori2001,87,1: | 1 |
| 10 | Tissue engineering of bone by osteo-induc- tive biomaterials显示文摘 | Ripamonti U Duneas N | 1996 | MRS Bu111996,21,6: | 1 |
| 11 | Clinical-practice recom- mendations for the management of bowel obstruction in patients with end-stage cancer 显示文摘 | Ripamonti C Twycross T Baines M | 2001 | Support Care Cancer2001,9,: | 1 |
| 12 | Proximal femur geometry to detect and distinguish femoral neck fractures from trochanteric fractures in postmenopausal women显示文摘 | Gnudi S Ripamonti C Lisi L | 2002 | Osteoporos Int2002,13,: | 1 |
| 13 | Sintered porous Hydroxyapatites with intrinsic osteoinductive activity: geometric induction of bone formation显示文摘 | Ripamonti U Crooks J Kirkbridc AN | 1999 | South African Journal of Science1999,95,8: | 1 |
| 14 | Man- agement of malignant bowel obstruction显示文摘 | RIPAMONTI C I EASSON A M GERDES H | 2008 | Eur J Cancer2008,44,: | 1 |
| 15 | Clinial-practice recommendations for the management of bowel obstruction in patients with end-stage cancer显示文摘 | Ripamonti C Twycross R Baines M | 2001 | Support Care Caner2001,9,4: | 1 |
| 16 | Severe hepatotoxicity during combination antiretroviral treatment:incidence,liver histology,and outcome显示文摘 | Puoti M Torti C Ripamonti D the HIV-HCV Co-infection Study Group | 2003 | J Acquir Immune Defic Syndr2003,32,: | 1 |
| 17 | Crystallization of calcium carbonate salts into beta-chitin scaffold显示文摘 | Giuseppe Falini Simona Fermani Alberto Ripamonti | 2002 | Journal of Inorganic Biochemistry2002,91,: | 1 |
| 18 | Palliative management of malignant bowel obstruction显示文摘 | Ripamonti C Bruera E | 2002 | Int J Cynecol Cancer2002,12,2: | 1 |
| 19 | Management of cancer pain : ESMO Clinical Practice Guidelines 显示文摘 | Ripamonti CI Santini D Maranzano E | 2012 | Ann Oncol2012,23,7: | 1 |
| 20 | The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results显示文摘 | Ripamonti C Panzeri C Groff L | 2001 | Tmnori2001,87,1: | 1 |